|
Montenegro MF, Marti-Diaz R, Navarro A, Tolivia J, Sanchez-Del-Campo L, Cabezas-Herrera J, Rodriguez-Lopez JN. Targeting protein methylation in pancreatic cancer cells results in KRAS signaling imbalance and inhibition of autophagy. Cell Death Dis. 2023 Nov 23;14(11):761. doi: 10.1038/s41419-023-06288-9. PubMed PMID: 37996408; PubMed Central PMCID: PMC10667277.
AÑO: 2023; IF: 8.1
|
|
Montenegro M.F., Martí-Díaz R., Navarro A., Tolivia J., Sánchez-del-Campo L., Cabezas-Herrera J., Rodríguez-López J.N. Targeting protein methylation in pancreatic cancer cells results in KRAS signaling imbalance and inhibition of autophagy. Cell Death and Disease. November 2023. 14. 10.1038/s41419-023-06288-9
AÑO: 2023; IF: 8.1
|
|
Martí-Díaz R., Montenegro M.F., Cabezas-Herrera J., Goding C.R., Rodríguez-López J.N., Sánchez-Del-campo L. Acriflavine, a potent inhibitor of HIF-1α, disturbs glucose metabolism and suppresses ATF4-protective pathways in melanoma under non-hypoxic conditions. Cancers. December 2021. 13:1-17. 10.3390/cancers13010102
AÑO: 2021; IF: 6.575
|
|
Montenegro M.F., González-Guerrero R., Sánchez-del-Campo L., Piñero-Madrona A., Cabezas-Herrera J., Rodríguez-López J.N. PRMT1-dependent methylation of BRCA1 contributes to the epigenetic defense of breast cancer cells against ionizing radiation. Scientific Reports. 1 December 2020. 10. 10.1038/s41598-020-70289-3
AÑO: 2020; IF: 4.379
|
|
Montenegro M.F., Sánchez-Del-Campo L., González-Guerrero R., Martínez-Barba E., Piñero-Madrona A., Cabezas-Herrera J., Rodríguez-López J.N. Tumor suppressor SET9 guides the epigenetic plasticity of breast cancer cells and serves as an early-stage biomarker for predicting metastasis. Oncogene. 24 November 2016. 35:6143-6152. 10.1038/onc.2016.154
AÑO: 2016; IF: 7.519
|